Document is current
Any future updates will be listed below
-
Authors
Singer, Barry A. https://orcid.org/0000-0001-6875-7374
Morgan, Dawn
Stamm, Julie A.
Williams, Anita A.
-
Funding
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
- License Information
-
More Information
Article History
Received: 10 July 2024
Accepted: 5 August 2024
First Online: 4 September 2024
Declarations
:
: Barry A. Singer has received research grant support from AbbVie, Biogen, Bristol Myers Squibb, Greenwich Biosciences, Novartis Pharmaceuticals Corporation, and Sanofi and consulting and/or speaking fees from Alexion, Biogen, Bristol Myers Squibb, Cigna, Cycle, EMD Serono, Genentech, Horizon, Janssen, Novartis Pharmaceuticals Corporation, Octave Bioscience, Roche, Sanofi, and TG Therapeutics. Dawn Morgan has nothing to disclose. Julie A. Stamm has done consulting work for EMD Serono and Novartis Pharmaceuticals Corporation. Anita A. Williams has done consulting work for EMD Serono, Genentech, Novartis Pharmaceuticals Corporation, and Octave Bioscience.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
